newsfilter
← Latest News
PR Newswire·

Atrium Therapeutics Reports First Quarter 2026 Financial Results

Atrium Therapeutics, Inc. (Nasdaq: RNA) ("Atrium," "Atrium Therapeutics" or the "Company"), a biopharmaceutical company advancing precision...